Assessing the onset of structural change in familial Alzheimer's disease

Annals of Neurology

Volumn 53, Issue 2, 2003, Pages 181-188

  Schott, Jonathan M ^a   Fox, Nick C ^a   Frost, Chris ^a,b   Scahill, Rachael I ^a   Janssen, John C ^a   Chan, Dennis ^a   Jenkins, Rhian ^a   Rossor, Martin N ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; BRAIN VENTRICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENTORHINAL CORTEX; FAMILIAL DISEASE; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYMPTOM; TEMPORAL LOBE;

ADULT; ALZHEIMER DISEASE; ATROPHY; BRAIN; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TEMPORAL LOBE;

EID: 0037308009     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10424     Document Type: Article

References (31)

1. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
2. Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet 1996;348:94-97.
3. Jack CR, Petersen RC, Xu Y, et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 1998;51:993-999.
4. Jack CR, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794.
5. Kelly CA, Harvey RJ, Cayton H. Drug treatments for Alzheimer's disease. Br Med J 1997;314:693-694.
6. Chan D, Fox NC, Scahill RI, et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol 2001;49:433-442.
7. Tandon A, Rogaeva E, Mullan M, et al. Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins. Curr Opin Neurol 2000;13:377-384.
8. Folstein M, Folstein S, McHugh P. "Mini mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975;12:189-198.
9. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
10. Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease: a longitudinal MRI study. Brain 1996;119:2001-2007.
11. Scahill RI, Schott JM, Stevens JM, et al. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 2002;99: 4703-4707.
12. Freeborough PA, Fox NC, Kitney RI. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 1997;53:15-25.
13. Freeborough PA, Woods RP, Fox NC. Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders. J Comput Assist Tomogr 1996;20:1012-1022.
14. Jenkins R, Fox NC, Rossor AM, et al. Intracranial volume and Alzheimer disease: evidence against the cerebral reserve hypothesis. Arch Neurol 2000;57:220-224.
15. Freeborough PA, Fox NC. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging 1997;16:623-629.
16. Duvernoy HM, Bougin P. The human hippocampus: functional anatomy, vascularization and serial sections with MRI. Heidelberg: Springer-Verlag, 1998.
17. Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42:1743-1750.
18. Insausti R, Juottonen K, Soininen H, et al. MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. Am J Neuroradiol 1998;19:659-671.
19. Buonaccorsi JP. Fieller's theorem. In: Armitage P, Colton T, eds. Encyclopaedia of Biostatistics. Chichester: Wiley, 1998: 1515-1516.
20. Fieller EC. The biological standardization of insulin. J R Stat Soc 1940;7:1-64.
21. Braak H, Braak E, Bohl J. Staging of Alzheimer-relaced cortical destruction. Eur Neurol 1993;33:403-408.
22. Bobinski M, de Leon MJ, Convit A, et al. MRI of entorhinal cortex in mild Alzheimer's disease. Lancet 1999;353:38-40.
23. Killiany RJ, Gomez-Isla T, Moss M, et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000;47:430-439.
24. Killiany RJ, Hyman BT, Gomez-Isla T, et al. MRI measures of entorhinal cortex vs hippocampus in predinical AD. Neurology 2002;58:1188-1196.
25. Xu Y, Jack CR Jr, O'Brien PC, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2000;54:1760-1767.
26. Pakkenberg B, Gundersen HJ. Neocortical neuron number in humans: effect of sex and age. J Comp Neurol 1997;384:312-320.
27. Fox NC, Freeborough PA. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J Magn Reson Imaging 1997;7:1069-1075.
28. Luxenberg JS, Haxby JV, Creasey H, et al. Rate of ventricular enlargement in dementia of the Alzheimer type correlates with rate of neuropsychological deterioration. Neurology 1987;37:1135-1140.
29. Callen DJ, Black SE, Gao F, et al. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 2001;57:1669-1674.
30. Baron JC, Chetelat G, Desgranges B, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001;14:298-309.
31. Jack CR, Petersen RC, Xu Y, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000;55:484-489.